Citation Impact
3 from Science/Nature 57 standout
Citing Papers
Lung cancer statistics, 2023
2024 Standout
Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
2024 Standout
Works of Jim Doherty being referenced
PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics
2018
Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial
2014
Author Peers
| Author | Education | PRM | Oncology | EE | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Jim Doherty | 74 | 179 | 259 | 90 | 35 | 634 | |
| Samuel Brooks | 2 | 21 | 153 | 11 | 593 | ||
| Wided Ben Ammar | 2 | 13 | 698 | ||||
| K. Andréeová | 2 | 14 | 376 | ||||
| P. C. M. Boers | 15 | 41 | 1.3k | ||||
| C. G. Moore | 3 | 2 | 53 | 749 |
All Works
Loading papers...